Skip to main content
. 2011 Nov 9;2011(11):CD002855. doi: 10.1002/14651858.CD002855.pub4

Wiebe 1999 A.

Methods see Wiebe 1999
Participants see Wiebe 1999
Interventions Phase 2: 
 group 1: 
 Tamoxifen 40 mg/day for 4 days (= total dose of 160mg) and misoprostol 800 mcg/pv > 48 hours 
 group 2: Methotrexate 50 mg/m2 and misoprostol 800mcg/pv >96 hours
Outcomes see Wiebe 1999
Notes see Wiebe 1999
Risk of bias
Bias Authors' judgement Support for judgement
Allocation concealment (selection bias) Low risk A ‐ Adequate